In the current study, we did find that the levels of MCPIP-1 were increased in neutrophils from both the peripheral blood and inflamed mucosa of IBD patients compared with healthy controls and observed that MCPIP-1 suppressed the production of ROS, MPO, and proinflammatory cytokines and inhibited the migration of IBD neutrophils. This evidence concerns the gene MPO and inflammatory bowel disease.